A patient with advanced hepatocellular carcinoma (liver cancer) who participated in the Phase II trials of namodenoson from Israel’s Can-Fite (see here previously) had an extremely good response. His liver function returned to normal, and he is looking forward to a good quality of life.
Liver cancer patient saved
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.